Identification of new drug targets in Mycobacterium avium and Mycobacterium tuberculosis.

作者信息

Rastogi N, Goh K S, Van Ginkel S Z, Wright E L, Barrow W W

机构信息

Unité de la Tuberculose et des Mycobactéries, Institut Pasteur de la Guadeloupe, Pointe-à-Pitre, Guadeloupe, French West Indies.

出版信息

Res Microbiol. 1996 Jan-Feb;147(1-2):97-105. doi: 10.1016/0923-2508(96)80210-5.

DOI:10.1016/0923-2508(96)80210-5

PMID:8761729

Abstract

摘要

相似文献

Identification of new drug targets in Mycobacterium avium and Mycobacterium tuberculosis.

Res Microbiol. 1996 Jan-Feb;147(1-2):97-105. doi: 10.1016/0923-2508(96)80210-5.

Synergistic activities of antituberculous drugs with cerulenin and trans-cinnamic acid against Mycobacterium tuberculosis.

FEMS Immunol Med Microbiol. 1998 Jun;21(2):149-57. doi: 10.1111/j.1574-695X.1998.tb01161.x.

The genetics of multiple drug resistance in Mycobacterium tuberculosis and the Mycobacterium avium complex.结核分枝杆菌和鸟分枝杆菌复合群中多重耐药性的遗传学

Res Microbiol. 1996 Jan-Feb;147(1-2):68-73. doi: 10.1016/0923-2508(96)80206-3.

Ribosomal drug resistance in mycobacteria.分枝杆菌中的核糖体耐药性。

Res Microbiol. 1996 Jan-Feb;147(1-2):59-67. doi: 10.1016/0923-2508(96)80205-1.

Prospects for development of new antimycobacterial drugs.新型抗分枝杆菌药物的研发前景。

J Infect Chemother. 2000 Mar;6(1):8-20. doi: 10.1007/s101560050043.

New rifabutin analogs: synthesis and biological activity against Mycobacterium tuberculosis.新型利福布汀类似物：抗结核分枝杆菌的合成及生物活性

Bioorg Med Chem Lett. 2006 Nov 15;16(22):5717-22. doi: 10.1016/j.bmcl.2006.08.090. Epub 2006 Sep 20.

Glycosyltransferases as targets for inhibition of cell wall synthesis in M. tuberculosis and M. avium.

Res Microbiol. 1996 Jan-Feb;147(1-2):106-12. doi: 10.1016/0923-2508(96)80211-7.

Intramacrophage passage of Mycobacterium tuberculosis and M. avium complex alters the drug susceptibilities of the organisms as determined by intracellular susceptibility testing using macrophages and type II alveolar epithelial cells.结核分枝杆菌和鸟分枝杆菌复合群在巨噬细胞内的传代改变了这些微生物的药物敏感性，这是通过使用巨噬细胞和II型肺泡上皮细胞进行细胞内药敏试验确定的。

Antimicrob Agents Chemother. 2002 Feb;46(2):519-21. doi: 10.1128/AAC.46.2.519-521.2002.

Prospects for development of new antimycobacterial drugs, with special reference to a new benzoxazinorifamycin, KRM-1648.新型抗分枝杆菌药物的研发前景，特别提及新型苯并恶嗪利福霉素KRM-1648

Arch Immunol Ther Exp (Warsz). 2000;48(3):183-8.

[Preclinical study of therapeutic agents used against Mycobacterium avium complex infections--with special reference to new macrolides and new quinolones].[抗鸟分枝杆菌复合群感染治疗药物的临床前研究——特别提及新型大环内酯类和新型喹诺酮类药物]

Kekkaku. 1996 Sep;71(9):531-5.

引用本文的文献

Monoclonal infection involving Mycobacterium avium presenting with three distinct colony morphotypes.涉及鸟分枝杆菌的单克隆感染，呈现出三种不同的菌落形态类型。

J Clin Microbiol. 1996 Oct;34(10):2475-8. doi: 10.1128/jcm.34.10.2475-2478.1996.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验